广信股份 20250428 摘要 • 农药行业自 2022 年下半年进入下行周期，受海运费上涨影响，2024 年 二季度毛利承压。草甘膦虽微利，但对公司氯气等配套产业链有积极作用， 有助于降低其他产品生产成本。 • 广信股份作为农药制剂龙头，面临草甘膦利润下降和多晶硅价格战的挑战。 新产品如恶草酮银松威有望在二季度陆续增量，改善业绩。公司需灵活调 整库存管理策略，应对市场变化。 • 当前行业库存较低，处于周期底部震荡阶段。下游客户受经济形势和贸易 战影响，采取随用随买策略，限制了价格大幅调整。公司历史上有明显的 补库和去库行为。 • 公司直接出口美国的销售额占比约 5%，草甘膦关税影响有限。农药农化 行业竞争稳定，但部分厂家退出市场，新安股份或将减少草甘膦业务投入， 行业集中度或将提升。 • 对硝基苯酚市场产能过剩，主要玩家包括杨龙集团、江苏南化和八一化工。 公司计划通过扩大印度市场来提高需求，以期在满负荷生产状态下降低成 本并提高收益。 Q&A 广信股份 2024 年和 2025 年一季度的财务表现如何？ 广信股份 2024 年的营业收入为 46.43 亿元，归母净利润为 7.79 亿元。2025 年一季度 ...

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company achieved significant year-on-year growth in Q1 2025, with revenue reaching 4.668 billion yuan, up 39.98% year-on-year and 46.04% quarter-on-quarter. The net profit attributable to shareholders was 515 million yuan, an increase of 49.61% year-on-year and 154.46% quarter-on-quarter [6][10] - The strong performance is attributed to robust sales of compound fertilizers, with a notable increase in both sales and profit [7][10] - The company is expected to continue benefiting from its integrated supply chain and increasing phosphate production capacity, enhancing its competitive advantage [10] Financial Performance Summary - In Q1 2025, the company reported: - Revenue: 4.668 billion yuan, up 39.98% year-on-year - Net profit: 515 million yuan, up 49.61% year-on-year - Gross profit: 848 million yuan, up 41.38% year-on-year - Return on Equity (ROE): 4.75%, an increase of 1.23 percentage points year-on-year [6][7] - The sales gross margin was 18.17%, up 0.19 percentage points year-on-year, while the net profit margin was 11.17%, up 0.90 percentage points year-on-year [6][7] Market Performance - The company's stock performance relative to the CSI 300 index showed: - 1-month performance: +3.4% - 3-month performance: +6.5% - 12-month performance: +17.5% [5] Future Projections - Revenue projections for 2025-2027 are as follows: - 2025: 18.5 billion yuan - 2026: 19.5 billion yuan - 2027: 20.3 billion yuan - Net profit projections for the same period are: - 2025: 1.6 billion yuan - 2026: 1.8 billion yuan - 2027: 2.0 billion yuan - Corresponding Price-to-Earnings (PE) ratios are expected to be 11, 9, and 8 times respectively [10][12]

证券代码：833819 证券简称：颖泰生物 公告编号：2025-030 北京颖泰嘉和生物科技股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 4 月 25 日 15:00–17:00 活 动 地 点 ： 公 司 通 过 全 景 网 " 投 资 者 关 系 互 动 平 台 " （https://ir.p5w.net）采用网络远程的方式召开业绩说明会 上市公司接待人员：公司董事长：陈伯阳先生 公司董事、总经理、董秘：刘晓亮先生 公司财务负责人：杨玉松先生 三、 投资者关系活动主要内容 本次业绩说明会通过年度报告解读、播放视频宣传片等形式对 公司情况及 2024 年年度经营业绩情况进行了介绍。同时，公司在 业绩说明会上就投资者关心的问题进行了回答，主要问题及回复如 下： 1、公司本期盈利水平如何？ 回 ...

上 市 公 司 基础化工 2025 年 04 月 28 日 润丰股份 (301035) —— 25Q1 业绩改善显著，to C 业务占比持续提升，中 长期价值值得期待 报告原因：有业绩公布需要点评 | 投资要点： | | --- | 财务数据及盈利预测 | | 2024 | 2025Q1 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万元） | 13,296 | 2,686 | 14,579 | 15,860 | 18,093 | | 同比增长率（%） | 15.8 | -0.3 | 9.6 | 8.8 | 14.1 | | 归母净利润（百万元） | 450 | 257 | 929 | 1,116 | 1,419 | | 同比增长率（%） | -41.6 | 68.0 | 106.5 | 20.0 | 27.2 | | 每股收益（元/股） | 1.61 | 0.91 | 3.31 | 3.97 | 5.06 | | 毛利率（%） | 19.8 | 19.3 | 20.2 | 20.6 | 21.0 | | RO ...

2025 年 04 月 28 日 公司研究 评级：买入(首次覆盖) 研究所： 证券分析师： 李永磊 S0350521080004 liyl03@ghzq.com.cn 证券分析师： 董伯骏 S0350521080009 dongbj@ghzq.com.cn 证券分析师： 陈云 S0350524070001 cheny17@ghzq.com.cn [Table_Title] 一季度业绩同比大幅提升，矿建加速推进 ——亚钾国际（000893）2024 年年报及 2025 年一季报点评 最近一年走势 | 相对沪深 300 | 表现 | | 2025/04/25 | | --- | --- | --- | --- | | 表现 | 1M | 3M | 12M | | 亚钾国际 | 14.3% | 51.4% | 56.6% | | 沪深 300 | -3.7% | -1.2% | 7.3% | | 市场数据 | | | 2025/04/25 | | 当前价格（元） | | | 29.22 | | 周价格区间（元） 52 | | | 13.65-29.30 | | 总市值（百万） | | | 27,000.78 | | ...

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company's Q1 performance was under pressure, with revenue of 7.772 billion yuan, a year-on-year decrease of 2.59% and a quarter-on-quarter decrease of 14.09%. The net profit attributable to shareholders was 707 million yuan, down 33.65% year-on-year and 17.20% quarter-on-quarter. The decline in sales of organic amines and acetic acid significantly impacted revenue and profit [8][12] - Despite the challenges, the company is expected to benefit from lower coal prices, which may reduce costs and improve performance in the future [8][12] - The company is actively advancing its construction projects, which are expected to provide new growth momentum [11][12] Summary by Sections Financial Performance - In Q1 2025, the company achieved revenue of 77.72 billion yuan, a decrease of 2.06 billion yuan year-on-year and 12.74 billion yuan quarter-on-quarter. Gross profit was 12.71 billion yuan, down 4.75 billion yuan year-on-year and 0.95 billion yuan quarter-on-quarter. The net profit attributable to shareholders was 7.07 billion yuan, down 3.58 billion yuan year-on-year and 1.47 billion yuan quarter-on-quarter [8][12] - The company's sales volume for fertilizers reached 1.4533 million tons, an increase of 36.74% year-on-year but a decrease of 3.91% quarter-on-quarter. Organic amines and acetic acid saw significant declines in sales volume [8][12] Market Conditions - The average price of urea in Q1 2025 was 1,734 yuan/ton, down 22% year-on-year and 3% quarter-on-quarter. The average price of acetic acid was 2,762 yuan/ton, down 8% year-on-year but up 4% quarter-on-quarter [8][12] - The company’s main product prices are currently experiencing low volatility, but the significant drop in coal prices is expected to improve the company's performance in the coming quarters [10][12] Future Outlook - The company forecasts revenues of 37.5 billion yuan, 41.2 billion yuan, and 45.6 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 4.46 billion yuan, 5.01 billion yuan, and 5.72 billion yuan for the same years. The corresponding P/E ratios are projected to be 10, 9, and 8 times [12][14] - The ongoing construction projects are expected to enhance the company's growth potential, supporting the positive outlook [11][12]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company has achieved a breakthrough in compound fertilizer sales, with a year-on-year revenue growth of 2.71% in 2024, reaching 10.263 billion yuan, and a net profit growth of 17.89%, totaling 826 million yuan [6][8] - The company is expected to continue its growth trajectory, with projected revenues of 13 billion yuan, 14.4 billion yuan, and 15.7 billion yuan for 2025, 2026, and 2027 respectively, alongside net profits of 998 million yuan, 1.202 billion yuan, and 1.407 billion yuan [14][41] Sales Performance - In 2024, the company sold 3.5128 million tons of phosphate fertilizers, a 12.18% increase year-on-year, with compound fertilizer sales reaching 3.3464 million tons, up 12.68% [8] - The company reported a revenue of 2.384 billion yuan in Q4 2024, a slight decrease of 0.24% year-on-year, but a 8.06% increase quarter-on-quarter [7] Financial Metrics - The company achieved a return on equity (ROE) of 13% in 2024, with a sales gross margin of 18.18%, reflecting a 0.70 percentage point increase year-on-year [6][8] - For Q1 2025, the company reported a revenue of 3.405 billion yuan, a 29.56% increase year-on-year, and a net profit of 288 million yuan, up 20.84% [11][29] Production Capacity - The company has a total production capacity of 7.2 million tons per year, with 5.9 million tons dedicated to compound fertilizers, and has established production bases across multiple provinces in China [12] Shareholder Returns - The company plans to distribute a cash dividend of 2.60 yuan per 10 shares, totaling approximately 299.49 million yuan, which represents 39.91% of the net profit attributable to shareholders for 2024 [13] Competitive Advantages - The company has established significant competitive advantages in brand strength, marketing channel development, new product research, and agricultural services, while actively advancing its phosphate chemical project to create a complete industrial chain [14][41]

Investment Rating - The investment rating for the company is "Outperform the Market" [5][27][32] Core Views - The company reported significant growth in revenue and net profit for Q1 2025, with revenue reaching 5.712 billion yuan (up 15.28% year-on-year) and net profit of 254 million yuan (up 18.99 year-on-year) [1][8] - The company plans to invest in a green chemical new energy materials project in Guigang, Guangxi, to fill the capacity gap in South China, which is expected to enhance profitability and risk resistance [2][26] - The prices of key products such as compound fertilizers, monoammonium phosphate, and yellow phosphorus have increased, contributing to the company's performance, with expectations for a slight price increase trend in Q2 2025 [2][19] Summary by Sections Financial Performance - In Q1 2025, the company's gross margin and net margin were 11.69% and 4.56%, respectively, both showing year-on-year increases [1][8] - The company’s non-recurring net profit was 250 million yuan, a substantial increase of 61.44% year-on-year [1][8] - The company’s revenue and net profit forecasts for 2025-2027 are 8.53 billion yuan, 9.72 billion yuan, and 11.19 billion yuan, with corresponding EPS of 0.71 yuan, 0.80 yuan, and 0.93 yuan [3][27] Market Trends - The average market price for chloride-based compound fertilizers was 2,394 yuan/ton in Q1 2025, reflecting a 2.48% increase from the previous quarter [2][19] - The average price for monoammonium phosphate was 3,126 yuan/ton, with a slight increase of 0.94% [2][13] - Yellow phosphorus prices averaged 23,283 yuan/ton in Q1 2025, with a 0.84% increase [2][24] Project Development - The planned project in Guigang will include the construction of various facilities with a total capacity of 1.2 million tons of high-efficiency compound fertilizers, 2 million tons of synthetic ammonia, and other chemical products [2][26] - This project aims to expand the company's production scale and improve its competitive position in the market [2][26] Industry Outlook - The phosphate chemical industry is expected to maintain a high price level due to the scarcity of resources and increasing demand in new sectors [12] - The company has established a complete industrial chain from upstream phosphate resources to downstream nitrogen fertilizers, enhancing its market position [3][27]

Core Insights - The company achieved a net profit of 87.92 million yuan in 2024, representing a year-on-year growth of 23.91%, and plans to distribute a total cash dividend of 20.23 million yuan [1] - The company is accelerating its modern agriculture layout by launching comprehensive solutions for cost reduction and yield increase [1] Financial Performance - The company forecasts net profits for 2025-2027 to be 157 million yuan, 200 million yuan, and 259 million yuan respectively, with corresponding EPS of 0.54, 0.69, and 0.90 yuan [2] - In 2024, the company reported operating revenue of 1.235 billion yuan, a year-on-year increase of 17.79%, and a net profit attributable to shareholders of 93.59 million yuan, up 30.81% [2] - The company plans to distribute a cash dividend of 0.70 yuan per 10 shares (tax included), totaling 20.23 million yuan [2] Business Segments - The overseas additives business saw a revenue increase of 12.48%, while domestic additives revenue grew by 4.93% to 358.38 million yuan [3] - The modern agriculture segment achieved revenue of 206.61 million yuan in 2024, marking a significant year-on-year growth of 169.05% [3] - The company has successfully launched multiple new products in the modern agriculture sector, including five new nematode control products and four new bio-fertilizers [3]

在全球粮食安全需求升级与农业现代化进程加速的背景下，农化行业正经历技术革新与产业整合的关键阶段，行业正经历从"量"到"质"的深刻 变革。 在农化行业迈向高质量发展的大潮中，凭借扎实的研发根基、清晰的战略布局及卓越的运营能力，泰禾股份不仅在国内市场稳居龙头，更在国 际舞台彰显中国智造的实力。 农化行业长坡厚雪，这是明牌。但是，在其中脱颖而出，要靠战略、管理和运营执行。在指挥得当的同时，还需要精细的微调手段，以求构建 宽广的护城河。一路走来，泰禾股份的成长历程，是一部浓缩中国农化企业"技术破壁、全球崛起"的奋斗史。二十余载深耕农化，，泰禾股份 在仿制中夯实根基，在创制中定义未来。泰禾股份正从仿制跟随实现到仿创领跑的华丽跨越。 在本次上市后，泰禾股份的产品力和创新力将进一步得到提升。这家公司将利用资本市场平台优势，进一步完善产业链、丰富产品组合、加强 创制产品的持续研发，以提升整体市场竞争优势。同时，公司将以上市为契机，扩大品牌影响力和知名度，推动主营业务的高质量发展和规范 运作。 随着创制产品放量、产业链协同深化，这家以创新为DNA的企业，必将迎来更广阔的星辰大海。 稳健经营 技术筑基 泰禾股份主要从事农药产品以 ...